2ND TRINAL Flashcards
Republic act no. 7719
National Blood Services Act of 1994.
Republic act no. 7719 was Enacted into law on
April 2, 1994
Republic act no. 7719 was approved on
May 5, 1994
Republic act no. 7719 was approved by
former president Fidel V. Ramos
Repealing R.A. No. 1517
Blood Blanking Law of 1956
the old blood banking law
Repealing R.A. No. 1517 (Blood Blanking Law
of 1956)
the old blood banking law was approved on
May 15, 1994
the old blood banking law was approved by
President Fidel V. Ramos.
the old blood banking law was Published in the official gazette on
August 18, 1994
the old blood banking law Took effect on
August 23, 1994
TWO MAJOR AGENCIES
Philippine National Red Cross (PNRC)
Philippine Blood Coordinating Council (PBCC)
RULES AND REGULATIONS IMPLEMENTING
REPUBLIC ACT No. 7719
Administrative Order No. 9, Series of 1995
the date promulgated by the
Secretary of the Department of Health (DOH).
April 28 1995.
AIDS was first described in
1979.
the first occurrence of AIDS was
described in an infant.
1982,
First case of HIV infection in the
Philippines was reported in
1984
ISBT
– International Society of Blood
Transfusion.
Revising the Blood Banking Law Guidelines
ADMINISTRATIVE ORDER NO. 57, SERIES OF
1989
- institutionalizing National Blood Services
Program (NBSP)
ADMINISTRATIVE ORDER NO. 118-A (1992)
- RULES AND REGULATIONS GOVERNING THE
REGULATION OF BLOOD SERVICE FACILITIES
ADMINISTRATIVE ORDER NO. 2008-0008
* May 2, 2008
Commercial Blood Banks paid donors
varying rates around
50-150 pesos.
NATIONAL VOLUNTARY BLOOD SERVICES
PROGRAM
PNRC
PBCC
government agencies
non-governmental organizations
– a unit, agency, or institution that provides blood products.
Blood Service Facility (BSF)
– substances derived from
whole blood or plasma are also called blood
components.
Blood Products
Blood Products
o Whole blood
o Packed red blood cells
o Granulocytes
o Plasma
o Platelets
o Cryoprecipitates
o Cryosupernates
- Blood collected within 24 hours
- Stored in a blood bag with the appropriate
anticoagulant. - Provides red blood cells (RBC), plasma, and
platelets. - After 48 hours, it is called whole blood (WB)
and contains the red cells and plasma
component of donor blood.
FRESH WHOLE BLOOD (FWB)
- Also called red cell concentrate, concentrated
red cells, or plasma-reduced cells) - Prepared by allowing blood to separate under
the influence of gravity overnight in a
refrigerator at a temperature of +2oC to +6oC
or by centrifuging the blood pack in a special
refrigerated centrifuge.
PACKED RED BLOOD CELLS
- Red cells washed with 0.9% sterile isotonic
saline using manual method to remove the
majority of plasma proteins, antibodies, and
electrolytes. - Depleted of plasma, platelets, and leukocytes.
WASHED RED CELLS
- Granulocytes collected through automation
(i.e., apheresis) - Apheresis (basophil, eosinophil, neutrophil)
GRANULOCYTES CONCENTRATE
- Blood component without most of its plasma
using a third-generation filter, either at the BSF
or at the patient’s bedside. - Red cells filtered most of its leukocytes.
- Leukocytes (basophil, eosinophil, neutrophil,
lymphocyte, monocyte)
LEUKOCYTE-DEPLETED (FILTERED) RED CELLS
- Also called random donor platelets
- Suspended in a small quantity of plasma
derived from whole blood within eight hours of
collection. - Platelet concentrates should be stored at a
temperature of between +20OC and +24OC
with continuous agitation.
PLATELET CONCENRATE
- Also referred as cryoprecipitate pool, cryo, or
pooled cryo. - Contains the cryoglobulin fraction of plasma
- Thawing one unit of FFP between 1OC – 6OC
and recovering the cold insoluble precipitate. - The cryoprecipitate is refrozen within one hour.
CRYOPRECIPITATE
- Also known as cryo-poor plasma
- Supernate plasma removed during the
preparation of cryoprecipitate. - It contains most clotting factors.
CRYOSUPERNATE
- Non-cellular fluid portion of the blood
separated from whole blood within 6 to 8
hours. Rapidly frozen and maintained at all times at a temperature of 30OC or lower.
FRESH FROZEN PLASMA (FFP)
BSFs may be classified as to:
o Ownership
o Institutional character
o Service capability
OWNERSHIP
Government BSFs
Private BSFs
o Owned, established, and operated by an
individual, corporation, association, or
organization.
Private BSFs
o Operated and maintained, partially or
wholly, by the:
▪ national government
▪ LGU (province, city, or municipality)
▪ Any other political unit or any
department, division, board, or
agency.
Government BSFs
INSTITUTIONAL CHARACTER
- Hospital-based
- Non-hospital-based
o Located within the premises of a hospital
Hospital-based
o Can be a government- or PRNC-owned BSF
located outside the premises of a hospital.
Non-hospital-based
- other hospitals and PNRC chapters rendering
blood services not classifies as BB/BC or BCU - regulated by the BRL
BLOOD STATION (BS)
- organized and established by Blood
Bank/Centers
BLOOD COLLECTION UNIT (BCU)
- Storage and issuance of whole blood and
blood components obtained from a BC
BLOOD BANK (BB)
- Hospital based
- Non-hospital based
- Commercial
- Testing of units of blood for transfusion
transmissible infections (TTIs
BLOOD BANK/CENTER
The TTIs screened by BCs are:
o Human Immunodeficiency Virus (HIV)
(determination of anti-HIV 1/2)
o Hepatitis B (determination of HBsAg)
o Hepatitis C (determination of anti HCV)
o Malaria
o Syphilis
Hospital-based blood stations
o must be managed by a ___________
certified by PSP
pathologist
Non-hospital-based blood stations
o ____________ formal
training in basic blood banking by a DOH-recognized training provider.
Physician with at least 3 months
Non-hospital-based BCUs, BS, and BS/BCU
___________________ in basic
blood banking provided by a DOH-recognized training provider
o Physician with formal training
BCs and blood banks is supervised by a
pathologist
hematologist
is an official permit issued by the
DOH to an individual, corporation,
partnership, or association to a BCU or BU
Authority to Operate (ATO)
is a formal authority issued by the
DOH to an individual, corporation
License to Operate (LTO)
are tasked to inspect and monitor BSF
the HFSRB and CHD
Person who gives blood freely and
voluntarily without payment
voluntary, non-remunerated blood donor
Licensed hospital that can perform
compatibility testing
End-Use Hospital
Non-hospital health facility that can
perform compatibility testing
End-User Non-hospital health facility
R.A. 9165
“Comprehensive Dangerous
Drugs Act of 2002”
This law mandates the Department of Health
to license, accredit, establish, and maintain a
drug test network and laboratory, initiate,
conduct, and support scientific research on
drugs and drug control
R.A. 9165 Comprehensive Dangerous
Drugs Act of 2002”
the date the DOH promulgated the
Implementing Rules and Regulations
Governing the Accreditation of Drug Testing
Laboratories in the Philippines
July 11, 2003
the date they designed a computer-based
system called Interim Drug Test Operations
and Management Information System
(IDTOMIS)
October 2003
– IDTOMIS was initiated
April 2006
is an integrated system that
captures data for accrediting DTLs and
rehabilitation centers, drug testing operations
at different levels of implementation,
verification of pending transactions, and
monitoring and evaluation of standards,
systems, and performance
Interim Drug Test Operations
and Management Information System
(IDTOMIS)
– DOH started the nationwide
implementation of IDTOMIS.
January 5, 2009
Comprehensive Dangerous Drugs Act of 2002
was Approved on
June 7, 2003
Comprehensive Dangerous Drugs Act of 2002
was signed by
Former President Gloria Macapagal-Arroyo
Repealed R.A. No. 6425, otherwise known as
the
Dangerous Drugs Act of 1972
Dangerous Drugs Act of 1972 consists of how many sections
102
is a private or government facility that is capable of testing a specimen to determine the presence. Of dangerous drugs therein
DTL – Drug Testing Laboratories
A DTL may be classified as
Ownership
Institutional Character
Service Capability
Service Capability
Screening Laboratories
Confirmatory Laboratories
Institutional Character
Institution-based DTLs
Freestanding DTLs
Ownership
Government DTLs
Private DTLs
are capable of performing screening tests.
Screening Laboratories
are capable of performing qualitative and
quantitative examinations of
dangerous drugs from the specimen.
Confirmatory Laboratories
R.A. No. 10586, otherwise known as
“Anti-Drunk and Drugged Driving Act of 2013.
Freestanding
screening DTLs must
be headed by:
- A pathologist; or
- a licensed physician
Confirmatory DTLs
must be headed by:
- a pathologist; or
- a chemist with
master’s degree in
chemistry or
biochemistry
Institution-based
screening DTLs must
be headed by a:
- Licensed physician;
- Chemist;
- medical technologist;
- pharmacist; or
- chemical engineer
A licensed physician is allowed to supervise at least
10 DTLs.
is a member of the laboratory personnel who collects specimens from a patient, client, or subject.
authorized specimen collector